{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:58:37Z","timestamp":1793501917320,"version":"4.5.0"},"reference-count":208,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T00:00:00Z","timestamp":1694217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T00:00:00Z","timestamp":1694217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s00203-023-03663-0","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T06:01:45Z","timestamp":1694239305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Emerging threat of antimicrobial resistance in Neisseria gonorrhoeae: pathogenesis, treatment challenges, and potential for vaccine development"],"prefix":"10.1007","volume":"205","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1097-8910","authenticated-orcid":false,"given":"Umairah Natasya Mohd","family":"Omeershffudin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5682-0938","authenticated-orcid":false,"given":"Suresh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,9]]},"reference":[{"key":"3663_CR1","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/01.olq.0000253346.41123.7c","volume":"34","author":"K Ahrens","year":"2007","unstructured":"Ahrens K, Bradbury KJ, Bauer HM, Samuel MC, Gould G, Donatoni G, Higgins C, Kerndt P, Bolan G (2007) Trends in the use of sexually transmitted disease diagnostic technologies in California, 1996\u20132003. Sex Transm Dis 34:513\u2013518","journal-title":"Sex Transm Dis"},{"key":"3663_CR2","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00284-021-02353-8","volume":"78","author":"GL Aitolo","year":"2021","unstructured":"Aitolo GL, Adeyemi OS, Afolabi BL, Owolabi AO (2021) Neisseria gonorrhoeae Antimicrobial Resistance: Past to Present to Future. Curr Microbiol 78:867\u2013878","journal-title":"Curr Microbiol"},{"key":"3663_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s101560170034","volume":"7","author":"S Akasaka","year":"2001","unstructured":"Akasaka S, Muratani T, Yamada Y, Inatomi H, Takahashi K, Matsumoto T (2001) Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce beta-lactamase. J Infect Chemother off J Japan Soc Chemother 7:49\u201350","journal-title":"J Infect Chemother off J Japan Soc Chemother"},{"key":"3663_CR4","doi-asserted-by":"publisher","unstructured":"Almonacid-Mendoza HL, Humbert MV, Dijokaite A, Cleary DW, Soo Y, Hung M-C, Orr CM, Machelett MM, Tews I, Christodoulides M (2018) Structure of the Recombinant Neisseria gonorrhoeae Adhesin Complex Protein (rNg-ACP) and Generation of Murine Antibodies with Bactericidal Activity against Gonococci. mSphere. https:\/\/doi.org\/10.1128\/mSphere.00331-18","DOI":"10.1128\/mSphere.00331-18"},{"key":"3663_CR5","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1128\/JB.00165-16","volume":"198","author":"MT Anderson","year":"2016","unstructured":"Anderson MT, Byerly L, Apicella MA, Steven Seifert H (2016) Seminal plasma promotes Neisseria gonorrhoeae aggregation and biofilm formation. J Bacteriol 198:2228\u20132235","journal-title":"J Bacteriol"},{"key":"3663_CR6","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.ARBA-0011-2017","author":"MF Anjum","year":"2017","unstructured":"Anjum MF, Zankari E, Hasman H (2017) Molecular Methods for Detection of Antimicrobial Resistance. Microbiol Spectr. https:\/\/doi.org\/10.1128\/microbiolspec.ARBA-0011-2017","journal-title":"Microbiol Spectr"},{"key":"3663_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.7774\/cevr.2019.8.2.110","volume":"8","author":"RFO Azze","year":"2019","unstructured":"Azze RFO (2019) A meningococcal B vaccine induces cross-protection against gonorrhea. Clin Exp Vaccine Res 8:110\u2013115","journal-title":"Clin Exp Vaccine Res"},{"key":"3663_CR8","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1093\/jac\/dkaa108","volume":"75","author":"LA Barbee","year":"2020","unstructured":"Barbee LA, Golden MR (2020) Aztreonam for Neisseria gonorrhoeae: a systematic review and meta-analysis. J Antimicrob Chemother 75:1685\u20131688","journal-title":"J Antimicrob Chemother"},{"key":"3663_CR9","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1093\/cid\/ciac043","volume":"74","author":"LA Barbee","year":"2022","unstructured":"Barbee LA, St Cyr SB (2022) Management of Neisseria gonorrhoeae in the United States: Summary of Evidence From the Development of the 2020 Gonorrhea Treatment Recommendations and the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infection Treatment Guidelines. Clin Infect Dis 74:S95\u2013S111","journal-title":"Clin Infect Dis"},{"key":"3663_CR10","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/OLQ.0000000000000093","volume":"41","author":"LA Barbee","year":"2014","unstructured":"Barbee LA, Dombrowski JC, Kerani R, Golden MR (2014) Effect of nucleic acid amplification testing on detection of extragenital gonorrhea and chlamydial infections in men who have sex with men sexually transmitted disease clinic patients. Sex Transm Dis 41:168\u2013172","journal-title":"Sex Transm Dis"},{"key":"3663_CR11","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1093\/cid\/cit070","volume":"56","author":"JG Bartlett","year":"2013","unstructured":"Bartlett JG, Gilbert DN, Spellberg B (2013) Seven ways to preserve the miracle of antibiotics. Clin Infect Dis an off Publ Infect Dis Soc Am 56:1445\u20131450","journal-title":"Clin Infect Dis an off Publ Infect Dis Soc Am"},{"key":"3663_CR12","doi-asserted-by":"publisher","first-page":"11827","DOI":"10.1038\/srep11827","volume":"5","author":"GS Basarab","year":"2015","unstructured":"Basarab GS, Kern GH, McNulty J et al (2015) Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases. Sci Rep 5:11827","journal-title":"Sci Rep"},{"key":"3663_CR13","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00401-19","author":"GA Beggs","year":"2019","unstructured":"Beggs GA, Zalucki YM, Brown NG, Rastegari S, Phillips RK, Palzkill T, Shafer WM, Kumaraswami M, Brennan RG (2019) Structural, Biochemical, and In Vivo Characterization of MtrR-Mediated Resistance to Innate Antimicrobials by the Human Pathogen Neisseria gonorrhoeae. J Bacteriol. https:\/\/doi.org\/10.1128\/JB.00401-19","journal-title":"J Bacteriol"},{"key":"3663_CR14","doi-asserted-by":"publisher","first-page":"32188","DOI":"10.1038\/srep32188","volume":"6","author":"J Bester","year":"2016","unstructured":"Bester J, Pretorius E (2016) Effects of IL-1\u03b2, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity. Sci Rep 6:32188","journal-title":"Sci Rep"},{"key":"3663_CR15","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1128\/JCM.02555-10","volume":"49","author":"MJ Binnicker","year":"2011","unstructured":"Binnicker MJ, Jespersen DJ, Rollins LO (2011) Treponema-specific tests for serodiagnosis of syphilis: Comparative evaluation of seven assays. J Clin Microbiol 49:1313\u20131317","journal-title":"J Clin Microbiol"},{"key":"3663_CR16","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2217\/fmb.14.66","volume":"9","author":"JMA Blair","year":"2014","unstructured":"Blair JMA, Richmond GE, Piddock LJV (2014) Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance. Future Microbiol 9:1165\u20131177","journal-title":"Future Microbiol"},{"key":"3663_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263437","volume":"17","author":"N Bogdani\u0107","year":"2022","unstructured":"Bogdani\u0107 N, Mo\u010dibob L, Vidovi\u0107 T, Soldo A, Begova\u0107 J (2022) Azithromycin consumption during the COVID-19 pandemic in Croatia, 2020. PLoS ONE 17:e0263437","journal-title":"PLoS ONE"},{"key":"3663_CR18","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1021\/acsinfecdis.0c00021","volume":"6","author":"PA Bradford","year":"2020","unstructured":"Bradford PA, Miller AA, O\u2019Donnell J, Mueller JP (2020) Zoliflodacin: An Oral Spiropyrimidinetrione Antibiotic for the Treatment of Neisseria gonorrheae, Including Multi-Drug-Resistant Isolates. ACS Infect Dis 6:1332\u20131345","journal-title":"ACS Infect Dis"},{"key":"3663_CR19","unstructured":"Bueno SA (2017) Improving the Detection and Surveillance of Sexually Transmitted Infections in Public Health Laboratories. 124"},{"key":"3663_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/emph\/eov018","volume":"2015","author":"AR Burmeister","year":"2015","unstructured":"Burmeister AR (2015) Horizontal Gene Transfer. Evol Med Public Heal 2015:193\u2013194","journal-title":"Evol Med Public Heal"},{"key":"3663_CR21","doi-asserted-by":"publisher","first-page":"4438","DOI":"10.1128\/IAI.00762-15","volume":"83","author":"DR Cash","year":"2015","unstructured":"Cash DR, Noinaj N, Buchanan SK, Cornelissen CN (2015) Beyond the Crystal Structure: Insight into the Function and Vaccine Potential of TbpA Expressed by Neisseria gonorrhoeae. Infect Immun 83:4438\u20134449","journal-title":"Infect Immun"},{"key":"3663_CR22","unstructured":"Centers for Disease Control and Prevention (CDC) New data suggest STDs continued to increase during first year of the COVID-19 pandemic | CDC Online Newsroom | CDC. https:\/\/www.cdc.gov\/media\/releases\/2022\/p0412-STD-Increase.html. Accessed 15 May 2023"},{"key":"3663_CR23","doi-asserted-by":"publisher","first-page":"5758387","DOI":"10.1155\/2016\/5758387","volume":"2016","author":"PA Chan","year":"2016","unstructured":"Chan PA, Robinette A, Montgomery M, Almonte A, Cu-Uvin S, Lonks JR, Chapin KC, Kojic EM, Hardy EJ (2016) Extragenital Infections Caused by Chlamydia trachomatis and Neisseria gonorrhoeae: A Review of the Literature. Infect Dis Obstet Gynecol 2016:5758387","journal-title":"Infect Dis Obstet Gynecol"},{"key":"3663_CR24","first-page":"139","volume":"176","author":"A Chateau","year":"2016","unstructured":"Chateau A, Steven Seifert H (2016) Neisseria gonorrhoeae survives within and modulates apoptosis and inflammatory cytokine production of human macrophages. HHS Public Access 176:139\u2013148","journal-title":"HHS Public Access"},{"key":"3663_CR25","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/iub.239","volume":"61","author":"A Chaudhury","year":"2009","unstructured":"Chaudhury A, Howe PH (2009) The tale of transforming growth factor-beta (TGFbeta) signaling: a soign\u00e9 enigma. IUBMB Life 61:929\u2013939","journal-title":"IUBMB Life"},{"key":"3663_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9111245","author":"C Chbib","year":"2021","unstructured":"Chbib C, Shah SM, Gala RP, Uddin MN (2021) Potential Applications of Microparticulate-Based Bacterial Outer Membrane Vesicles (OMVs) Vaccine Platform for Sexually Transmitted Diseases (STDs): Gonorrhea, Chlamydia, and Syphilis. Vaccines. https:\/\/doi.org\/10.3390\/vaccines9111245","journal-title":"Vaccines"},{"key":"3663_CR27","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12879-016-1435-0","volume":"16","author":"Y Chen","year":"2016","unstructured":"Chen Y, Gong Y, Yang T, Song X, Li J, Gan Y, Yin X, Lu Z (2016) Antimicrobial resistance in Neisseria gonorrhoeae in China: a meta-analysis. BMC Infect Dis 16:108","journal-title":"BMC Infect Dis"},{"key":"3663_CR28","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S1473-3099(19)30116-1","volume":"19","author":"MY Chen","year":"2019","unstructured":"Chen MY, McNulty A, Avery A et al (2019a) Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): a randomised phase 3 non-inferiority trial. Lancet Infect Dis 19:833\u2013842","journal-title":"Lancet Infect Dis"},{"key":"3663_CR29","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/cid\/ciy566","volume":"68","author":"XS Chen","year":"2019","unstructured":"Chen XS, Yin YP, Li XY (2019b) A ROADMAP plan to address research needs for gonococcal antimicrobial resistance in China. Clin Infect Dis 68:505\u2013510","journal-title":"Clin Infect Dis"},{"key":"3663_CR30","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nature11400","volume":"488","author":"I Cho","year":"2012","unstructured":"Cho I, Yamanishi S, Cox L et al (2012) Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488:621\u2013626","journal-title":"Nature"},{"key":"3663_CR31","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00534-17","author":"CP Churchward","year":"2017","unstructured":"Churchward CP, Alany RG, Kirk RS, Walker AJ, Snyder LAS (2017) Prevention of Ophthalmia Neonatorum Caused by Neisseria gonorrhoeae Using a Fatty Acid-Based Formulation. Mbio. https:\/\/doi.org\/10.1128\/mBio.00534-17","journal-title":"Mbio"},{"key":"3663_CR32","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1093\/jac\/dks162","volume":"67","author":"J \u0106mara","year":"2012","unstructured":"\u0106mara J, Serra J, Ayats J, Bastida T, Carnicer-Pont D, Andreu A, Ardanuy C (2012) Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J Antimicrob Chemother 67:1858\u20131860","journal-title":"J Antimicrob Chemother"},{"key":"3663_CR33","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0140-6736(00)41665-X","volume":"232","author":"AJ Cokkinis","year":"1938","unstructured":"Cokkinis AJ, Mcelligott GLM (1938) SULPHANILAMIDE IN GONORRH\u0152A: AN ANALYSIS OF 633 CASES. Lancet 232:355\u2013362","journal-title":"Lancet"},{"key":"3663_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148986","volume":"11","author":"DO Connor","year":"2016","unstructured":"Connor DO, Zantow J, Hust M, Bier FF, von Nickisch-Rosenegk M (2016) Identification of Novel Immunogenic Proteins of Neisseria gonorrhoeae by Phage Display. PLoS ONE 11:e0148986","journal-title":"PLoS ONE"},{"key":"3663_CR35","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1128\/AAC.47.12.3877-3880.2003","volume":"47","author":"SJ Cousin","year":"2003","unstructured":"Cousin SJ, Whittington WLH, Roberts MC (2003) Acquired macrolide resistance genes in pathogenic Neisseria spp. isolated between 1940 and 1987. Antimicrob Agents Chemother 47:3877\u20133880","journal-title":"Antimicrob Agents Chemother"},{"key":"3663_CR36","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.cell.2014.05.052","volume":"158","author":"LM Cox","year":"2014","unstructured":"Cox LM, Yamanishi S, Sohn J et al (2014) Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158:705\u2013721","journal-title":"Cell"},{"key":"3663_CR37","doi-asserted-by":"publisher","first-page":"4520","DOI":"10.1016\/j.vaccine.2015.07.015","volume":"33","author":"AP Craig","year":"2015","unstructured":"Craig AP, Gray RT, Edwards JL, Apicella MA, Jennings MP, Wilson DP, Seib KL (2015) The potential impact of vaccination on the prevalence of gonorrhea. Vaccine 33:4520\u20134525","journal-title":"Vaccine"},{"key":"3663_CR38","first-page":"139","volume":"176","author":"AP Craiga","year":"2015","unstructured":"Craiga AP, Graya RT, Edwardsb JL, Apicellac MA, Jenningsd MP, David P, Wilson a and KLS, (2015) The potential impact of vaccination on the prevalence of gonorrhea. HHS Public Access 176:139\u2013148","journal-title":"HHS Public Access"},{"key":"3663_CR39","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.15585\/mmwr.mm6950a6","volume":"69","author":"SS Cyr","year":"2020","unstructured":"Cyr SS, Barbee L, Workowski KA, Bachmann LH, Pham C, Schlanger K (2020) Update to CDC\u2019s Treatment Guidelines for Gonococcal Infection, 2020. Morb Mortal Wkly Rep Updat 69:1911\u20131916","journal-title":"Morb Mortal Wkly Rep Updat"},{"key":"3663_CR40","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jmwh.2009.09.003","volume":"55","author":"EK Darling","year":"2010","unstructured":"Darling EK, McDonald H (2010) A meta-analysis of the efficacy of ocular prophylactic agents used for the prevention of gonococcal and chlamydial ophthalmia neonatorum. J Midwifery Womens Health 55:319\u2013327","journal-title":"J Midwifery Womens Health"},{"key":"3663_CR41","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/S0140-6736(13)60604-2","volume":"381","author":"SC Davies","year":"2013","unstructured":"Davies SC, Fowler T, Watson J, Livermore DM, Walker D (2013) Annual Report of the Chief Medical Officer: infection and the rise of antimicrobial resistance. Lancet 381:1606\u20131609","journal-title":"Lancet"},{"key":"3663_CR42","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S1473-3099(19)30115-X","volume":"19","author":"HJC de Vries","year":"2019","unstructured":"de Vries HJC, Schim-van der Loeff MF (2019) Solithromycin for the treatment of drug-resistant gonorrhoea. Lancet Infect Dis 19:791\u2013792","journal-title":"Lancet Infect Dis"},{"key":"3663_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10156-002-0204-8","volume":"9","author":"T Deguchi","year":"2003","unstructured":"Deguchi T, Yasuda M, Yokoi S et al (2003) Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval. J Infect Chemother off J Japan Soc Chemother 9:35\u201339","journal-title":"J Infect Chemother off J Japan Soc Chemother"},{"key":"3663_CR44","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/infdis\/jiz504","volume":"221","author":"X Deng","year":"2020","unstructured":"Deng X, Klausner JD (2020) Six penA Codons Accurately and Reliably Predict Cefixime-Decreased Susceptibility in Neisseria gonorrhoeae. J Infect Dis 221:851\u2013852","journal-title":"J Infect Dis"},{"key":"3663_CR45","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1071\/SH18227","volume":"16","author":"X Deng","year":"2019","unstructured":"Deng X, Allan-Blitz L-T, Klausner JD (2019) Using the genetic characteristics of Neisseria gonorrhoeae strains with decreased susceptibility to cefixime to develop a molecular assay to predict cefixime susceptibility. Sex Health 16:488\u2013499","journal-title":"Sex Health"},{"key":"3663_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-020-00805-7","volume":"9","author":"A Derbie","year":"2020","unstructured":"Derbie A, Mekonnen D, Woldeamanuel Y, Abebe T (2020) Azithromycin resistant gonococci: A literature review. Antimicrob Resist Infect Control 9:1\u20137","journal-title":"Antimicrob Resist Infect Control"},{"issue":"Suppl","key":"3663_CR47","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.1073\/pnas.1000087107","volume":"108","author":"L Dethlefsen","year":"2011","unstructured":"Dethlefsen L, Relman DA (2011) Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 108(Suppl):4554\u20134561","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3663_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0060280","volume":"6","author":"L Dethlefsen","year":"2008","unstructured":"Dethlefsen L, Huse S, Sogin ML, Relman DA (2008) The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6:e280","journal-title":"PLoS Biol"},{"key":"3663_CR49","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/14787210.2016.1178064","volume":"14","author":"J-WH Dik","year":"2016","unstructured":"Dik J-WH, Hendrix R, Poelman R, Niesters HG, Postma MJ, Sinha B, Friedrich AW (2016) Measuring the impact of antimicrobial stewardship programs. Expert Rev Anti Infect Ther 14:569\u2013575","journal-title":"Expert Rev Anti Infect Ther"},{"key":"3663_CR50","first-page":"1","volume":"35","author":"J Dillon","year":"2015","unstructured":"Dillon J, Parti R, Thakur S (2015) Antibiotic Resistance in Neisseria gonorrhoeae: Will Infections be Untreatable in the Future? Culture 35:1\u20138","journal-title":"Culture"},{"key":"3663_CR51","first-page":"98","volume":"69","author":"GG Donders","year":"1993","unstructured":"Donders GG, Desmyter J, De Wet DH, Van Assche FA (1993) The association of gonorrhoea and syphilis with premature birth and low birthweight. Genitourin Med 69:98\u2013101","journal-title":"Genitourin Med"},{"key":"3663_CR52","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.4065\/mcp.2011.0358","volume":"86","author":"S Doron","year":"2011","unstructured":"Doron S, Davidson LE (2011) Antimicrobial stewardship. Mayo Clin Proc 86:1113\u20131123","journal-title":"Mayo Clin Proc"},{"key":"3663_CR53","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1128\/AAC.30.5.649","volume":"30","author":"TJ Dougherty","year":"1986","unstructured":"Dougherty TJ (1986) Genetic analysis and penicillin-binding protein alterations in Neisseria gonorrhoeae with chromosomally mediated resistance. Antimicrob Agents Chemother 30:649\u2013652","journal-title":"Antimicrob Agents Chemother"},{"key":"3663_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/48.suppl_2.1","volume":"48","author":"S Douthwaite","year":"2001","unstructured":"Douthwaite S, Champney WS (2001) Structures of ketolides and macrolides determine their mode of interaction with the ribosomal target site. J Antimicrob Chemother 48:1\u20138","journal-title":"J Antimicrob Chemother"},{"key":"3663_CR55","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1128\/IAI.74.5.2767-2776.2006","volume":"74","author":"Y Du","year":"2006","unstructured":"Du Y, Arvidson CG (2006) RpoH mediates the expression of some, but not all, genes induced in Neisseria gonorrhoeae adherent to epithelial cells. Infect Immun 74:2767\u20132776","journal-title":"Infect Immun"},{"key":"3663_CR56","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1080\/10408398.2020.1843396","volume":"62","author":"H Duan","year":"2022","unstructured":"Duan H, Yu L, Tian F, Zhai Q, Fan L, Chen W (2022) Antibiotic-induced gut dysbiosis and barrier disruption and the potential protective strategies. Crit Rev Food Sci Nutr 62:1427\u20131452","journal-title":"Crit Rev Food Sci Nutr"},{"key":"3663_CR57","doi-asserted-by":"crossref","unstructured":"Edwards JL, Apicella MA (2004a) The Molecular Mechanisms Used by Neisseria gonorrhoeae To Initiate Infection Differ between Men and Women. Society 17:965\u2013981","DOI":"10.1128\/CMR.17.4.965-981.2004"},{"key":"3663_CR58","doi-asserted-by":"crossref","unstructured":"Edwards JL, Apicella MA (2004c) The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women. Clin Microbiol Rev 17:965\u201381, table of contents","DOI":"10.1128\/CMR.17.4.965-981.2004"},{"key":"3663_CR59","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1128\/CMR.17.4.965-981.2004","volume":"17","author":"JL Edwards","year":"2004","unstructured":"Edwards JL, Apicella MA (2004b) The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women. Clin Microbiol Rev 17:965\u2013981","journal-title":"Clin Microbiol Rev"},{"key":"3663_CR60","doi-asserted-by":"publisher","first-page":"5602","DOI":"10.1038\/s41598-020-62696-3","volume":"10","author":"A Elkashif","year":"2020","unstructured":"Elkashif A, Seleem MN (2020) Investigation of auranofin and gold-containing analogues antibacterial activity against multidrug-resistant Neisseria gonorrhoeae. Sci Rep 10:5602","journal-title":"Sci Rep"},{"key":"3663_CR61","unstructured":"European Molecular Biology Laboratory (2021) Tackling the collateral damage from antibiotics: Scientists pave the way for reducing the harmful side effects antibiotics have on gut bacteria -- ScienceDaily. https:\/\/www.sciencedaily.com\/releases\/2021\/10\/211013114015.htm. Accessed 17 May 2023"},{"key":"3663_CR62","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3201\/eid2301.161205","volume":"23","author":"CK Fairley","year":"2017","unstructured":"Fairley CK, Hocking JS, Zhang L, Chow EPF (2017) Frequent transmission of gonorrhea in men who have sex with men. Emerg Infect Dis 23:102\u2013104","journal-title":"Emerg Infect Dis"},{"key":"3663_CR63","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g4233","author":"Y Fang","year":"2014","unstructured":"Fang Y (2014) China should curb non-prescription use of antibiotics in the community. BMJ. https:\/\/doi.org\/10.1136\/bmj.g4233","journal-title":"BMJ"},{"key":"3663_CR64","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02047-16","author":"DJ Farrell","year":"2017","unstructured":"Farrell DJ, Sader HS, Rhomberg PR, Scangarella-Oman NE, Flamm RK (2017) In Vitro Activity of Gepotidacin (GSK2140944) against Neisseria gonorrhoeae. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.02047-16","journal-title":"Antimicrob Agents Chemother"},{"key":"3663_CR65","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1056\/NEJM198509053131004","volume":"313","author":"H Faruki","year":"1985","unstructured":"Faruki H, Kohmescher RN, McKinney WP, Sparling PF (1985) A community-based outbreak of infection with penicillin-resistant Neisseria gonorrhoeae not producing penicillinase (chromosomally mediated resistance). N Engl J Med 313:607\u2013611","journal-title":"N Engl J Med"},{"key":"3663_CR66","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/S1473-3099(19)30430-X","volume":"19","author":"P Fernandes","year":"2019","unstructured":"Fernandes P, Craft JC (2019) Phase 3 trial of treating gonorrhoea with solithromycin. Lancet Infect Dis 19:928","journal-title":"Lancet Infect Dis"},{"key":"3663_CR67","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1093\/jac\/dkz376","volume":"74","author":"S Foerster","year":"2019","unstructured":"Foerster S, Drusano G, Golparian D, Neely M, Piddock LJV, Alirol E, Unemo M (2019) In vitro antimicrobial combination testing of and evolution of resistance to the first-in-class spiropyrimidinetrione zoliflodacin combined with six therapeutically relevant antimicrobials for Neisseria gonorrhoeae. J Antimicrob Chemother 74:3521\u20133529","journal-title":"J Antimicrob Chemother"},{"key":"3663_CR68","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1128\/JB.01165-08","volume":"191","author":"JP Folster","year":"2009","unstructured":"Folster JP, Johnson PJT, Jackson L, Dhulipali V, Dyer DW, Shafer WM (2009) MtrR modulates rpoH expression and levels of antimicrobial resistance in Neisseria gonorrhoeae. J Bacteriol 191:287\u2013297","journal-title":"J Bacteriol"},{"key":"3663_CR69","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1101\/gr.155465.113","volume":"23","author":"K Forslund","year":"2013","unstructured":"Forslund K, Sunagawa S, Kultima JR, Mende DR, Arumugam M, Typas A, Bork P (2013) Country-specific antibiotic use practices impact the human gut resistome. Genome Res 23:1163\u20131169","journal-title":"Genome Res"},{"key":"3663_CR70","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3389\/fcimb.2017.00502","volume":"7","author":"C Foschi","year":"2017","unstructured":"Foschi C, Salvo M, Cevenini R, Parolin C, Vitali B, Marangoni A (2017) Vaginal Lactobacilli Reduce Neisseria gonorrhoeae Viability through Multiple Strategies: An in Vitro Study. Front Cell Infect Microbiol 7:502","journal-title":"Front Cell Infect Microbiol"},{"key":"3663_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines6030060","author":"RP Gala","year":"2018","unstructured":"Gala RP, Zaman RU, D\u2019Souza MJ, Zughaier SM (2018) Novel Whole-Cell Inactivated Neisseria gonorrhoeae Microparticles as Vaccine Formulation in Microneedle-Based Transdermal Immunization. Vaccines. https:\/\/doi.org\/10.3390\/vaccines6030060","journal-title":"Vaccines"},{"key":"3663_CR72","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1136\/sextrans-2016-052581","volume":"93","author":"NJ Garrett","year":"2017","unstructured":"Garrett NJ, McGrath N, Mindel A (2017) Advancing STI care in low\/middle-income countries: has STI syndromic management reached its use-by date? Sex Transm Infect 93:4\u20135","journal-title":"Sex Transm Infect"},{"key":"3663_CR73","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1128\/AAC.00036-12","volume":"56","author":"D Golparian","year":"2012","unstructured":"Golparian D, Fernandes P, Ohnishi M, Jensen JS, Unemo M (2012) In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with high-level antimicrobial resistance: potential treatment o. Antimicrob Agents Chemother 56:2739\u20132742","journal-title":"Antimicrob Agents Chemother"},{"key":"3663_CR74","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1128\/AAC.00038-14","volume":"58","author":"D Golparian","year":"2014","unstructured":"Golparian D, Shafer WM, Ohnishi M, Unemo M (2014) Importance of multidrug efflux pumps in the antimicrobial resistance property of clinical multidrug-resistant isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother 58:3556\u20133559","journal-title":"Antimicrob Agents Chemother"},{"key":"3663_CR75","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3389\/fimmu.2019.00321","volume":"10","author":"S Gulati","year":"2019","unstructured":"Gulati S, Shaughnessy J, Ram S, Rice PA (2019a) Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine. Front Immunol 10:321","journal-title":"Front Immunol"},{"key":"3663_CR76","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02552-19","author":"S Gulati","year":"2019","unstructured":"Gulati S, Pennington MW, Czerwinski A et al (2019b) Preclinical Efficacy of a Lipooligosaccharide Peptide Mimic Candidate Gonococcal Vaccine. Mbio. https:\/\/doi.org\/10.1128\/mBio.02552-19","journal-title":"Mbio"},{"key":"3663_CR77","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/cid\/ciz170","volume":"70","author":"Y Han","year":"2020","unstructured":"Han Y, Yin Y, Dai X et al (2020) Widespread Use of High-dose Ceftriaxone Therapy for Uncomplicated Gonorrhea Without Reported Ceftriaxone Treatment Failure: Results From 5 Years of Multicenter Surveillance Data in China. Clin Infect Dis an off Publ Infect Dis Soc Am 70:99\u2013105","journal-title":"Clin Infect Dis an off Publ Infect Dis Soc Am"},{"key":"3663_CR78","unstructured":"Health Department of Republic of South Africa (2015) Sexually Transmitted Infections Management Guidelines 2015."},{"key":"3663_CR79","unstructured":"Heel RNB and RC (1986) Aztreonam A Review of its Antibacterial Activity, Pharmacokinetic Properties and Therapeutic Use. ADIS Drug Inf. Serv. Auckl."},{"key":"3663_CR80","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1128\/JCM.03032-15","volume":"54","author":"P Hemarajata","year":"2016","unstructured":"Hemarajata P, Yang S, Soge OO, Humphries RM, Klausner JD (2016) Performance and Verification of a Real-Time PCR Assay Targeting the gyrA Gene for Prediction of Ciprofloxacin Resistance in Neisseria gonorrhoeae. J Clin Microbiol 54:805\u2013808","journal-title":"J Clin Microbiol"},{"key":"3663_CR81","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/OLQ.0000000000000592","volume":"44","author":"CL Heumann","year":"2017","unstructured":"Heumann CL, Quilter LAS, Eastment MC, Heffron R, Hawes SE (2017) Adverse Birth Outcomes and Maternal Neisseria gonorrhoeae Infection: A Population-Based Cohort Study in Washington State. Sex Transm Dis 44:266\u2013271","journal-title":"Sex Transm Dis"},{"key":"3663_CR82","doi-asserted-by":"publisher","first-page":"4743","DOI":"10.1128\/IAI.00687-07","volume":"75","author":"DL Higashi","year":"2007","unstructured":"Higashi DL, Lee SW, Snyder A, Weyand NJ, Bakke A, So M (2007) Dynamics of Neisseria gonorrhoeae attachment: microcolony development, cortical plaque formation, and cytoprotection. Infect Immun 75:4743\u20134753","journal-title":"Infect Immun"},{"key":"3663_CR83","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/oxfordjournals.aje.a121125","volume":"91","author":"KK Holmes","year":"1970","unstructured":"Holmes KK, Johnson DW, Trostle HJ (1970) An estimate of the risk of men acquiring gonorrhea by sexual contact with infected females. Am J Epidemiol 91:170\u2013174","journal-title":"Am J Epidemiol"},{"key":"3663_CR84","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/oxfordjournals.aje.a112597","volume":"108","author":"RR Hooper","year":"1978","unstructured":"Hooper RR, Reynolds GH, Jones OG et al (1978) Cohort study of venereal disease. I: the risk of gonorrhea transmission from infected women to men. Am J Epidemiol 108:136\u2013144","journal-title":"Am J Epidemiol"},{"key":"3663_CR85","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1128\/AAC.04124-14","volume":"59","author":"MD Huband","year":"2015","unstructured":"Huband MD, Bradford PA, Otterson LG et al (2015) In vitro antibacterial activity of AZD0914, a new spiropyrimidinetrione DNA gyrase\/topoisomerase inhibitor with potent activity against Gram-positive, fastidious Gram-Negative, and atypical bacteria. Antimicrob Agents Chemother 59:467\u2013474","journal-title":"Antimicrob Agents Chemother"},{"key":"3663_CR86","doi-asserted-by":"publisher","first-page":"3926","DOI":"10.1016\/j.vaccine.2018.05.069","volume":"36","author":"MV Humbert","year":"2018","unstructured":"Humbert MV, Christodoulides M (2018) Immunization with recombinant truncated Neisseria meningitidis-Macrophage Infectivity Potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for Neisseria gonorrhoeae. Vaccine 36:3926\u20133936","journal-title":"Vaccine"},{"key":"3663_CR87","doi-asserted-by":"crossref","unstructured":"Ison CA, Hussey J, Sankar KN, Evans J, Alexander S (2011) Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Euro Surveill. Bull. Eur. sur les Mal. Transm. = Eur. Commun. Dis. Bull. 16:","DOI":"10.2807\/ese.16.14.19833-en"},{"key":"3663_CR88","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1615\/CritRevImmunol.v32.i1.30","volume":"32","author":"SS Iyer","year":"2012","unstructured":"Iyer SS, Cheng G (2012) Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol 32:23\u201363","journal-title":"Crit Rev Immunol"},{"key":"3663_CR89","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1093\/jac\/dky162","volume":"73","author":"S Jacobsson","year":"2018","unstructured":"Jacobsson S, Golparian D, Scangarella-Oman N, Unemo M (2018) In vitro activity of the novel triazaacenaphthylene gepotidacin (GSK2140944) against MDR Neisseria gonorrhoeae. J Antimicrob Chemother 73:2072\u20132077","journal-title":"J Antimicrob Chemother"},{"key":"3663_CR90","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01479-19","author":"S Jacobsson","year":"2019","unstructured":"Jacobsson S, Kularatne R, Kittiyaowamarn R et al (2019) High in vitro susceptibility to the first-in-class spiropyrimidinetrione zoliflodacin among consecutive clinical Neisseria gonorrhoeae isolates from Thailand (2018) and South Africa (2015\u20132017). Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.01479-19","journal-title":"Antimicrob Agents Chemother"},{"key":"3663_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.682135","volume":"12","author":"S Jacobsson","year":"2021","unstructured":"Jacobsson S, Golparian D, Oxelbark J, Alirol E, Franceschi F, Gustafsson TN, Brown D, Louie A, Drusano G, Unemo M (2021) Pharmacodynamic Evaluation of Dosing, Bacterial Kill, and Resistance Suppression for Zoliflodacin Against Neisseria gonorrhoeae in a Dynamic Hollow Fiber Infection Model. Front Pharmacol 12:682135","journal-title":"Front Pharmacol"},{"key":"3663_CR92","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1056\/NEJM197601012940102","volume":"294","author":"HW Jaffe","year":"1976","unstructured":"Jaffe HW, Biddle JW, Thornsberry C, Johnson RE, Kaufman RE, Reynolds GH, Wiesner PJ (1976) National gonorrhea therapy monitoring study: in vitro antibiotic susceptibility and its correlation with treatment results. N Engl J Med 294:5\u20139","journal-title":"N Engl J Med"},{"key":"3663_CR93","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/j.vaccine.2013.08.067","volume":"32","author":"AE Jerse","year":"2014","unstructured":"Jerse AE, Bash MC, Russell MW (2014) Vaccines against gonorrhea: current status and future challenges. Vaccine 32:1579\u20131587","journal-title":"Vaccine"},{"key":"3663_CR94","doi-asserted-by":"crossref","unstructured":"Jerse AE, Deal CD (2013) Vaccine research for gonococcal infections: where are we? Sex Transm Infect 89 Suppl 4:iv63\u20138","DOI":"10.1136\/sextrans-2013-051225"},{"key":"3663_CR95","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1093\/jac\/dkz339","volume":"74","author":"CM John","year":"2019","unstructured":"John CM, Li M, Feng D, Jarvis GA (2019) Cationic cell-penetrating peptide is bactericidal against Neisseria gonorrhoeae. J Antimicrob Chemother 74:3245\u20133251","journal-title":"J Antimicrob Chemother"},{"key":"3663_CR96","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/apm.12777","volume":"126","author":"A J\u00f6nsson","year":"2018","unstructured":"J\u00f6nsson A, Foerster S, Golparian D, Hamasuna R, Jacobsson S, Lindberg M, Jensen JS, Ohnishi M, Unemo M (2018) In vitro activity and time-kill curve analysis of sitafloxacin against a global panel of antimicrobial-resistant and multidrug-resistant Neisseria gonorrhoeae isolates. APMIS 126:29\u201337","journal-title":"APMIS"},{"key":"3663_CR97","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/00007435-198304000-00007","volume":"10","author":"RH Kampmeier","year":"1983","unstructured":"Kampmeier RH (1983) Introduction of sulfonamide therapy for gonorrhea. Sex Transm Dis 10:81\u201384","journal-title":"Sex Transm Dis"},{"key":"3663_CR98","doi-asserted-by":"publisher","unstructured":"Kenyon C (2019) Comment on \u201cEffectiveness of a Group B outer membrane vesicle meningococcal vaccine in preventing hospitalization from gonorrhea in New Zealand: a retrospective cohort study, Vaccines, 2019, 1, 5; doi:https:\/\/doi.org\/10.3390\/vaccines7010005\u201d. Vaccines. https:\/\/doi.org\/10.3390\/vaccines7010031","DOI":"10.3390\/vaccines7010005 10.3390\/vaccines7010031"},{"key":"3663_CR99","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0924-8579(01)00317-X","volume":"17","author":"M Kol\u00e1\u0159","year":"2001","unstructured":"Kol\u00e1\u0159 M, Urb\u00e1nek K, L\u00e1tal T (2001) Antibiotic selective pressure and development of bacterial resistance. Int J Antimicrob Agents 17:357\u2013363","journal-title":"Int J Antimicrob Agents"},{"key":"3663_CR100","doi-asserted-by":"publisher","unstructured":"Kularatne R, Maseko V, Gumede L, Kufa T (2018) Trends in Neisseria gonorrhoeae Antimicrobial Resistance over a Ten-Year Surveillance Period, Johannesburg, South Africa, 2008\u22122017. Antibiot (Basel, Switzerland). https:\/\/doi.org\/10.3390\/antibiotics7030058","DOI":"10.3390\/antibiotics7030058"},{"key":"3663_CR101","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1146\/annurev.micro.091208.073413","volume":"64","author":"A Kulp","year":"2010","unstructured":"Kulp A, Kuehn MJ (2010) Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu Rev Microbiol 64:163\u2013184","journal-title":"Annu Rev Microbiol"},{"key":"3663_CR102","first-page":"24","volume":"16","author":"S Kumar","year":"2020","unstructured":"Kumar S (2020) In silico identification of novel tuberculosis drug targets in mycobacterium tuberculosis P450 enzymes by interaction study with Azole drugs. Malaysian J Med Heal Sci 16:24\u201330","journal-title":"Malaysian J Med Heal Sci"},{"key":"3663_CR103","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1136\/sextrans-2018-053950","volume":"95","author":"A Lau","year":"2019","unstructured":"Lau A, Kong FYS, Huston W, Chow EPF, Fairley CK, Hocking JS (2019) Factors associated with anorectal Chlamydia trachomatis or Neisseria gonorrhoeae test positivity in women: a systematic review and meta-analysis. Sex Transm Infect 95:361\u2013367","journal-title":"Sex Transm Infect"},{"key":"3663_CR104","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/QCO.0000000000000025","volume":"27","author":"DA Lewis","year":"2014","unstructured":"Lewis DA (2014) Global resistance of Neisseria gonorrhoeae: when theory becomes reality. Curr Opin Infect Dis 27:62\u201367","journal-title":"Curr Opin Infect Dis"},{"key":"3663_CR105","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1093\/jac\/dkw013","volume":"71","author":"H Lin","year":"2016","unstructured":"Lin H, Dyar OJ, Rosales-Klintz S, Zhang J, Tomson G, Hao M, St\u00e5lsby Lundborg C (2016) Trends and patterns of antibiotic consumption in Shanghai municipality, China: a 6 year surveillance with sales records, 2009\u201314. J Antimicrob Chemother 71:1723\u20131729","journal-title":"J Antimicrob Chemother"},{"key":"3663_CR106","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1093\/infdis\/jiaa495","volume":"223","author":"EY Lin","year":"2021","unstructured":"Lin EY, Adamson PC, Deng X, Klausner JD (2021) Establishing Novel Molecular Algorithms to Predict Decreased Susceptibility to Ceftriaxone in Neisseria gonorrhoeae Strains. J Infect Dis 223:1232\u20131240","journal-title":"J Infect Dis"},{"key":"3663_CR107","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/mi.2012.12","volume":"5","author":"Y Liu","year":"2012","unstructured":"Liu Y, Islam EA, Jarvis GA, Gray-Owen SD, Russell MW (2012) Neisseria gonorrhoeae selectively suppresses the development of Th1 and Th2 cells, and enhances Th17 cell responses, through TGF-\u03b2-dependent mechanisms. Mucosal Immunol 5:320\u2013331","journal-title":"Mucosal Immunol"},{"key":"3663_CR108","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1136\/sextrans-2013-051118","volume":"89","author":"B Liu","year":"2013","unstructured":"Liu B, Roberts CL, Clarke M, Jorm L, Hunt J, Ward J (2013) Chlamydia and gonorrhoea infections and the risk of adverse obstetric outcomes: a retrospective cohort study. Sex Transm Infect 89:672\u2013678","journal-title":"Sex Transm Infect"},{"key":"3663_CR109","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/mi.2013.36","volume":"7","author":"Y Liu","year":"2014","unstructured":"Liu Y, Liu W, Russell MW (2014) Suppression of host adaptive immune responses by Neisseria gonorrhoeae: role of interleukin 10 and type 1 regulatory T cells. Mucosal Immunol 7:165\u2013176","journal-title":"Mucosal Immunol"},{"key":"3663_CR110","doi-asserted-by":"publisher","unstructured":"Liu Y, Perez J, Hammer LA, Gallagher HC, De Jesus M, Egilmez NK, Russell MW (2018) Intravaginal Administration of Interleukin 12 during Genital Gonococcal Infection in Mice Induces Immunity to Heterologous Strains of Neisseria gonorrhoeae. mSphere. https:\/\/doi.org\/10.1128\/mSphere.00421-17","DOI":"10.1128\/mSphere.00421-17"},{"key":"3663_CR111","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1097\/AOG.0000000000002804","volume":"132","author":"E Llata","year":"2018","unstructured":"Llata E, Braxton J, Asbel L, Chow J, Jenkins L, Murphy R, Pathela P, Schumacher C, Torrone E (2018) Rectal Chlamydia trachomatis and Neisseria gonorrhoeae Infections Among Women Reporting Anal Intercourse. Obstet Gynecol 132:692\u2013697","journal-title":"Obstet Gynecol"},{"key":"3663_CR112","doi-asserted-by":"crossref","unstructured":"Lu S, Grimes-Serrano JM, Wang S (2009) DNA Vaccines for Biodefense and Emerging and Neglected Infectious Diseases. Vaccines Biodefense Emerg Neglected Dis 93\u2013114","DOI":"10.1016\/B978-0-12-369408-9.00008-1"},{"key":"3663_CR113","doi-asserted-by":"publisher","first-page":"27994","DOI":"10.1021\/acsami.0c06163","volume":"12","author":"MI Luc\u00edo","year":"2020","unstructured":"Luc\u00edo MI, Kyriazi M-E, Hamilton J, Batista D, Sheppard A, Sams-Dodd E, Humbert MV, Hussain I, Christodoulides M, Kanaras AG (2020) Bactericidal Effect of 5-Mercapto-2-nitrobenzoic Acid-Coated Silver Nanoclusters against Multidrug-Resistant Neisseria gonorrhoeae. ACS Appl Mater Interfaces 12:27994\u201328003","journal-title":"ACS Appl Mater Interfaces"},{"key":"3663_CR114","first-page":"525","volume":"27","author":"JF Mahoney","year":"1943","unstructured":"Mahoney JF, Ferguson C, Buchholtz M, Van Slyke CJ et al (1943) The Use of Penicillin Sodium in the Treatment of Sulfonamide. Resistant Gonorrhoea in Men. A Preliminary Report Am J Syph 27:525\u2013528","journal-title":"A Preliminary Report Am J Syph"},{"key":"3663_CR115","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.881392","volume":"12","author":"SA Maurakis","year":"2022","unstructured":"Maurakis SA, Cornelissen CN (2022) Recent Progress Towards a Gonococcal Vaccine. Front Cell Infect Microbiol 12:881392","journal-title":"Front Cell Infect Microbiol"},{"key":"3663_CR116","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/0002-9378(92)91369-L","volume":"166","author":"GL Maxwell","year":"1992","unstructured":"Maxwell GL, Watson WJ (1992) Preterm premature rupture of membranes: results of expectant management in patients with cervical cultures positive for group B streptococcus or Neisseria gonorrhoeae. Am J Obstet Gynecol 166:945\u2013949","journal-title":"Am J Obstet Gynecol"},{"key":"3663_CR117","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1128\/AAC.30.5.664","volume":"30","author":"SA Morse","year":"1986","unstructured":"Morse SA, Johnson SR, Biddle JW, Roberts MC (1986) High-level tetracycline resistance in Neisseria gonorrhoeae is result of acquisition of streptococcal tetM determinant. Antimicrob Agents Chemother 30:664\u2013670","journal-title":"Antimicrob Agents Chemother"},{"key":"3663_CR118","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1517\/17530050902860229","volume":"3","author":"E Munson","year":"2009","unstructured":"Munson E, Firmani MA (2009) Molecular diagnosis of Neisseria gonorrhoeae infection in the United States. Expert Opin Med Diagn 3:327\u2013343","journal-title":"Expert Opin Med Diagn"},{"key":"3663_CR119","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJL Murray","year":"2022","unstructured":"Murray CJL, Ikuta KS, Sharara F et al (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399:629\u2013655","journal-title":"Lancet"},{"key":"3663_CR120","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01808-18","author":"J O\u2019Donnell","year":"2019","unstructured":"O\u2019Donnell J, Lawrence K, Vishwanathan K, Hosagrahara V, Mueller JP (2019) Single-Dose Pharmacokinetics, Excretion, and Metabolism of Zoliflodacin, a Novel Spiropyrimidinetrione Antibiotic, in Healthy Volunteers. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.01808-18","journal-title":"Antimicrob Agents Chemother"},{"key":"3663_CR121","unstructured":"of Sexually Transmitted Infection JS (2011) Gonococcal infection. Sexually transmitted infections, diagnosis and treatment guidelines 2011. Jpn J Sex Transm Dis 22:529"},{"key":"3663_CR122","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1128\/AAC.01010-09","volume":"54","author":"M Ohnishi","year":"2010","unstructured":"Ohnishi M, Watanabe Y, Ono E, Takahashi C, Oya H, Kuroki T, Shimuta K, Okazaki N, Nakayama S, Watanabe H (2010) Spread of a chromosomal cefixime-resistant penA gene among different Neisseria gonorrhoeae lineages. Antimicrob Agents Chemother 54:1060\u20131067","journal-title":"Antimicrob Agents Chemother"},{"key":"3663_CR123","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1128\/AAC.00325-11","volume":"55","author":"M Ohnishi","year":"2011","unstructured":"Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, Nakayama S, Kitawaki J, Unemo M (2011) Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 55:3538\u20133545","journal-title":"Antimicrob Agents Chemother"},{"key":"3663_CR124","doi-asserted-by":"crossref","unstructured":"Omeershffudin Umairah Natasya Mohd Kumar Suresh (2022) Antimicrobial resistance in Klebsiella pneumoniae: identification of bacterial DNA adenine methyltransferase as a novel drug target from hypothetical proteins using subtractive genomics. Genomics Inf 20:e47-","DOI":"10.5808\/gi.22067"},{"key":"3663_CR125","doi-asserted-by":"crossref","unstructured":"Omeershffudin Umairah Natasya Mohd Kumar Suresh (2023) Antibiotic Resistance in Neisseria Gonnorhoeae:A Broad-spectrum Drug Target Identification by Using Subtractive Genomics. Genomics Inform.","DOI":"10.5808\/gi.22066"},{"key":"3663_CR126","doi-asserted-by":"publisher","first-page":"512","DOI":"10.4067\/S0716-10182021000400512","volume":"38","author":"M Ortiz","year":"2021","unstructured":"Ortiz M, Edgardo Santander P, Judith Lugo P (2021) Neisseria gonorrhoeae: a wayward pathogen. Microbiological concepts, antimicrobial resistance and its epidemiological surveillance in Chile. Rev Chilena Infectol 38:512\u2013522","journal-title":"Rev Chilena Infectol"},{"key":"3663_CR127","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/s41564-018-0257-9","volume":"3","author":"A Palleja","year":"2018","unstructured":"Palleja A, Mikkelsen KH, Forslund SK et al (2018) Recovery of gut microbiota of healthy adults following antibiotic exposure. Nat Microbiol 3:1255\u20131265","journal-title":"Nat Microbiol"},{"key":"3663_CR128","doi-asserted-by":"publisher","first-page":"S341","DOI":"10.1086\/382690","volume":"38","author":"DL Paterson","year":"2004","unstructured":"Paterson DL (2004) \u201cCollateral Damage\u201d from Cephalosporin or Quinolone Antibiotic Therapy. Clin Infect Dis 38:S341\u2013S345","journal-title":"Clin Infect Dis"},{"key":"3663_CR129","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/S0140-6736(17)31449-6","volume":"390","author":"H Petousis-Harris","year":"2017","unstructured":"Petousis-Harris H, Paynter J, Morgan J, Saxton P, McArdle B, Goodyear-Smith F, Black S (2017) Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study. Lancet 390:1603\u20131610","journal-title":"Lancet"},{"key":"3663_CR130","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.03046-19","author":"J Poole","year":"2020","unstructured":"Poole J, Day CJ, Haselhorst T, Jen FE-C, Torres VJ, Edwards JL, Jennings MP (2020) Repurposed Drugs That Block the Gonococcus-Complement Receptor 3 Interaction Can Prevent and Cure Gonococcal Infection of Primary Human Cervical Epithelial Cells. Mbio. https:\/\/doi.org\/10.1128\/mBio.03046-19","journal-title":"Mbio"},{"key":"3663_CR131","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","volume":"109","author":"F Prestinaci","year":"2015","unstructured":"Prestinaci F, Pezzotti P, Pantosti A (2015) Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health 109:309\u2013318","journal-title":"Pathog Glob Health"},{"key":"3663_CR132","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1128\/IAI.73.7.3945-3953.2005","volume":"73","author":"GA Price","year":"2005","unstructured":"Price GA, Russell MW, Cornelissen CN (2005) Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice. Infect Immun 73:3945\u20133953","journal-title":"Infect Immun"},{"key":"3663_CR133","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1084\/jem.193.3.281","volume":"193","author":"S Ram","year":"2001","unstructured":"Ram S, Cullinane M, Blom AM et al (2001) Binding of C4b-binding protein to porin: A molecular mechanism of serum resistance of Neisseria gonorrhoeae. J Exp Med 193:281\u2013295","journal-title":"J Exp Med"},{"key":"3663_CR134","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/emph\/eou024","volume":"2014","author":"AF Read","year":"2014","unstructured":"Read AF, Woods RJ (2014) Antibiotic resistance management. Evol Med Public Heal 2014:147","journal-title":"Evol Med Public Heal"},{"key":"3663_CR135","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1146\/annurev-micro-090816-093530","volume":"71","author":"PA Rice","year":"2017","unstructured":"Rice PA, Shafer WM, Ram S, Jerse AE (2017a) Neisseria gonorrhoeae: Drug Resistance, Mouse Models, and Vaccine Development. Annu Rev Microbiol 71:665\u2013686","journal-title":"Annu Rev Microbiol"},{"key":"3663_CR136","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1146\/annurev-micro-090816-093530","volume":"71","author":"PA Rice","year":"2017","unstructured":"Rice PA, Shafer WM, Ram S, Jerse AE (2017b) Neisseria gonorrhoeae\u202f: Drug Resistance, Mouse Models, and Vaccine Development. Annu Rev Microbiol 71:665\u2013686","journal-title":"Annu Rev Microbiol"},{"key":"3663_CR137","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1042\/bj0750620","volume":"75","author":"C Rimington","year":"1960","unstructured":"Rimington C (1960) Spectral-absorption coefficients of some porphyrins in the Soret-band region. Biochem J 75:620\u2013623","journal-title":"Biochem J"},{"key":"3663_CR138","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1101\/gr.265058.120","volume":"31","author":"M Roodgar","year":"2021","unstructured":"Roodgar M, Good BH, Garud NR et al (2021) Longitudinal linked-read sequencing reveals ecological and evolutionary responses of a human gut microbiome during antibiotic treatment. Genome Res 31:1433\u20131446","journal-title":"Genome Res"},{"key":"3663_CR139","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1146\/annurev-genet-120213-092007","volume":"48","author":"E Rotman","year":"2014","unstructured":"Rotman E, Seifert HS (2014) The genetics of Neisseria species. Annu Rev Genet 48:405\u2013431","journal-title":"Annu Rev Genet"},{"key":"3663_CR140","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/s41467-017-00531-6","volume":"8","author":"VE Ruiz","year":"2017","unstructured":"Ruiz VE, Battaglia T, Kurtz ZD et al (2017) A single early-in-life macrolide course has lasting effects on murine microbial network topology and immunity. Nat Commun 8:518","journal-title":"Nat Commun"},{"key":"3663_CR141","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1093\/infdis\/jiaa766","volume":"224","author":"MW Russell","year":"2021","unstructured":"Russell MW (2021) Immune Responses to Neisseria gonorrhoeae: Challenges and Opportunities With Respect to Pelvic Inflammatory Disease. J Infect Dis 224:S96\u2013S102","journal-title":"J Infect Dis"},{"key":"3663_CR142","doi-asserted-by":"publisher","first-page":"395","DOI":"10.4155\/tde.13.4","volume":"4","author":"C Russell","year":"2013","unstructured":"Russell C, Rahman A, Mohammed AR (2013) Application of genomics, proteomics and metabolomics in drug discovery, development and clinic. Ther Deliv 4:395\u2013413","journal-title":"Ther Deliv"},{"key":"3663_CR143","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cytogfr.2010.09.002","volume":"21","author":"R Sabat","year":"2010","unstructured":"Sabat R, Gr\u00fctz G, Warszawska K, Kirsch S, Witte E, Wolk K, Geginat J (2010) Biology of interleukin-10. Cytokine Growth Factor Rev 21:331\u2013344","journal-title":"Cytokine Growth Factor Rev"},{"key":"3663_CR144","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1136\/sextrans-2022-055518","volume":"99","author":"NE Scangarella-Oman","year":"2023","unstructured":"Scangarella-Oman NE, Hossain M, Perry CR, Tiffany C, Powell M, Swift B, Dumont EF (2023) Dose selection for a phase III study evaluating gepotidacin (GSK2140944) in the treatment of uncomplicated urogenital gonorrhoea. Sex Transm Infect 99:64\u201369","journal-title":"Sex Transm Infect"},{"key":"3663_CR145","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.physbeh.2017.03.040","volume":"176","author":"QSJ Seifert","year":"2017","unstructured":"Seifert QSJ, HS, (2017) Neisseria gonoorrhoeae host-adaptation and pathogenesis. Physiol Behav 176:139\u2013148","journal-title":"Physiol Behav"},{"key":"3663_CR146","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/infdis\/jiz628","volume":"221","author":"EA Semchenko","year":"2020","unstructured":"Semchenko EA, Mubaiwa TD, Day CJ, Seib KL (2020) Role of the Gonococcal Neisserial Heparin Binding Antigen in Microcolony Formation, and Serum Resistance and Adherence to Epithelial Cells. J Infect Dis 221:1612\u20131622","journal-title":"J Infect Dis"},{"key":"3663_CR147","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1017\/S095026881600234X","volume":"145","author":"J Serra-Pladevall","year":"2017","unstructured":"Serra-Pladevall J, Barber\u00e1 MJ, Callarisa AE, Bartolom\u00e9-Comas R, Andreu A (2017) Differences in Neisseria gonorrhoeae population structure and antimicrobial resistance pattern between men who have sex with men and heterosexuals. Epidemiol Infect 145:379\u2013385","journal-title":"Epidemiol Infect"},{"key":"3663_CR148","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-39658-3","author":"WM Shafer","year":"2016","unstructured":"Shafer WM, Yu EW, Rouquette-loughlin C, Golparian D, Jerse AE, Unemo M (2016) Efflux Pumps in Neisseria gonorrhoeae\u202f: Contributions to Antimicrobial Resistance and Virulence. Efflux-Mediated Antimicrob Resist Bact. https:\/\/doi.org\/10.1007\/978-3-319-39658-3","journal-title":"Efflux-Mediated Antimicrob Resist Bact"},{"key":"3663_CR149","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10091699","author":"B Shaskolskiy","year":"2022","unstructured":"Shaskolskiy B, Kandinov I, Dementieva E, Gryadunov D (2022) Antibiotic Resistance in Neisseria gonorrhoeae: Challenges in Research and Treatment. Microorganisms. https:\/\/doi.org\/10.3390\/microorganisms10091699","journal-title":"Microorganisms"},{"key":"3663_CR150","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.bbrc.2012.12.132","volume":"431","author":"LK Shewell","year":"2013","unstructured":"Shewell LK, Ku SC, Schulz BL, Jen FE-C, Mubaiwa TD, Ketterer MR, Apicella MA, Jennings MP (2013) Recombinant truncated AniA of pathogenic Neisseria elicits a non-native immune response and functional blocking antibodies. Biochem Biophys Res Commun 431:215\u2013220","journal-title":"Biochem Biophys Res Commun"},{"key":"3663_CR151","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0732-8893(96)00183-6","volume":"26","author":"VD Shortridge","year":"1996","unstructured":"Shortridge VD, Flamm RK, Ramer N, Beyer J, Tanaka SK (1996) Novel mechanism of macrolide resistance in Streptococcus pneumoniae. Diagn Microbiol Infect Dis 26:73\u201378","journal-title":"Diagn Microbiol Infect Dis"},{"key":"3663_CR152","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1128\/JCM.01909-06","volume":"45","author":"MJ Siedner","year":"2007","unstructured":"Siedner MJ, Pandori M, Castro L, Barry P, Whittington WLH, Liska S, Klausner JD (2007) Real-time PCR assay for detection of quinolone-resistant Neisseria gonorrhoeae in urine samples. J Clin Microbiol 45:1250\u20131254","journal-title":"J Clin Microbiol"},{"key":"3663_CR153","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00186-17","author":"AE Sikora","year":"2017","unstructured":"Sikora AE, Mills RH, Weber JV, Hamza A, Passow BW, Romaine A, Williamson ZA, Reed RW, Zielke RA, Korotkov KV (2017) Peptide Inhibitors Targeting the Neisseria gonorrhoeae Pivotal Anaerobic Respiration Factor AniA. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.00186-17","journal-title":"Antimicrob Agents Chemother"},{"key":"3663_CR154","doi-asserted-by":"publisher","first-page":"8175","DOI":"10.1016\/j.vaccine.2020.10.077","volume":"38","author":"AE Sikora","year":"2020","unstructured":"Sikora AE, Gomez C, Le Van A, Baarda BI, Darnell S, Martinez FG, Zielke RA, Bonventre JA, Jerse AE (2020) A novel gonorrhea vaccine composed of MetQ lipoprotein formulated with CpG shortens experimental murine infection. Vaccine 38:8175\u20138184","journal-title":"Vaccine"},{"key":"3663_CR155","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193678","volume":"13","author":"V Singh","year":"2018","unstructured":"Singh V, Bala M, Bhargava A, Kakran M, Bhatnagar R (2018a) In vitro efficacy of 21 dual antimicrobial combinations comprising novel and currently recommended combinations for treatment of drug resistant gonorrhoea in future era. PLoS ONE 13:e0193678","journal-title":"PLoS ONE"},{"key":"3663_CR156","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/OLQ.0000000000000708","volume":"45","author":"V Singh","year":"2018","unstructured":"Singh V, Bala M, Bhargava A, Kakran M, Bhatnagar R (2018b) In Vitro Synergy Testing of Gentamicin, an Old Drug Suggested as Future Treatment Option for Gonorrhoea, in Combination With Six Other Antimicrobials Against Multidrug-Resistant Neisseria gonorrhoeae Strains. Sex Transm Dis 45:127\u2013131","journal-title":"Sex Transm Dis"},{"key":"3663_CR157","doi-asserted-by":"publisher","first-page":"345","DOI":"10.4103\/ijmr.IJMR_1979_17","volume":"150","author":"S Singh","year":"2019","unstructured":"Singh S, Verma N, Taneja N (2019) The human gut resistome: Current concepts & future prospects. Indian J Med Res 150:345\u2013358","journal-title":"Indian J Med Res"},{"key":"3663_CR158","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1128\/AAC.02798-15","volume":"60","author":"OO Soge","year":"2016","unstructured":"Soge OO, Salipante SJ, No D, Duffy E, Roberts MC (2016) In Vitro Activity of Delafloxacin against Clinical Neisseria gonorrhoeae Isolates and Selection of Gonococcal Delafloxacin Resistance. Antimicrob Agents Chemother 60:3106\u20133111","journal-title":"Antimicrob Agents Chemother"},{"key":"3663_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2020.102182","volume":"62","author":"J S\u00f3ki","year":"2020","unstructured":"S\u00f3ki J, Wybo I, Hajd\u00fa E et al (2020) A Europe-wide assessment of antibiotic resistance rates in Bacteroides and Parabacteroides isolates from intestinal microbiota of healthy subjects. Anaerobe 62:102182","journal-title":"Anaerobe"},{"issue":"Suppl 2","key":"3663_CR160","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1093\/cid\/ciu392","volume":"59","author":"B Spellberg","year":"2014","unstructured":"Spellberg B, Gilbert DN (2014) The future of antibiotics and resistance: a tribute to a career of leadership by John Bartlett. Clin Infect Dis an off Publ Infect Dis Soc Am 59(Suppl 2):S71\u2013S75","journal-title":"Clin Infect Dis an off Publ Infect Dis Soc Am"},{"key":"3663_CR161","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1128\/IAI.01200-09","volume":"78","author":"RR Spurbeck","year":"2010","unstructured":"Spurbeck RR, Arvidson CG (2010) Lactobacillus jensenii surface-associated proteins inhibit Neisseria gonorrhoeae adherence to epithelial cells. Infect Immun 78:3103\u20133111","journal-title":"Infect Immun"},{"key":"3663_CR162","doi-asserted-by":"publisher","unstructured":"Suay-Garc\u00eda B, P\u00e9rez-Gracia MT (2018) Future Prospects for Neisseria gonorrhoeae Treatment. Antibiot (Basel, Switzerland). https:\/\/doi.org\/10.3390\/antibiotics7020049","DOI":"10.3390\/antibiotics7020049"},{"key":"3663_CR163","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s10096-017-2931-x","volume":"36","author":"B Suay-Garc\u00eda","year":"2017","unstructured":"Suay-Garc\u00eda B, P\u00e9rez-Gracia MT (2017) Drug-resistant Neisseria gonorrhoeae: latest developments. Eur J Clin Microbiol Infect Dis 36:1065\u20131071","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3663_CR164","doi-asserted-by":"publisher","first-page":"10364","DOI":"10.1002\/chem.201801602","volume":"24","author":"Y Sun","year":"2018","unstructured":"Sun Y, Zhang J, Zhang Y, Liu J, van der Veen S, Duttwyler S (2018) The closo-Dodecaborate Dianion Fused with Oxazoles Provides 3D Diboraheterocycles with Selective Antimicrobial Activity. Chemistry 24:10364\u201310371","journal-title":"Chemistry"},{"key":"3663_CR165","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1128\/AAC.40.8.1817","volume":"40","author":"J Sutcliffe","year":"1996","unstructured":"Sutcliffe J, Tait-Kamradt A, Wondrack L (1996) Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother 40:1817\u20131824","journal-title":"Antimicrob Agents Chemother"},{"key":"3663_CR166","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s101560200011","volume":"8","author":"M Tanaka","year":"2002","unstructured":"Tanaka M, Nakayama H, Tunoe H, Egashira T, Kanayama A, Saika T, Kobayashi I, Naito S (2002) A remarkable reduction in the susceptibility of Neisseria gonorrhoeae isolates to cephems and the selection of antibiotic regimens for the single-dose treatment of gonococcal infection in Japan. J Infect Chemother off J Japan Soc Chemother 8:81\u201386","journal-title":"J Infect Chemother off J Japan Soc Chemother"},{"key":"3663_CR167","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0891-5849(00)00460-3","volume":"30","author":"C Tanielian","year":"2001","unstructured":"Tanielian C, Schweitzer C, Mechin R, Wolff C (2001) Quantum yield of singlet oxygen production by monomeric and aggregated forms of hematoporphyrin derivative. Free Radic Biol Med 30:208\u2013212","journal-title":"Free Radic Biol Med"},{"key":"3663_CR168","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/cid\/ciy145","volume":"67","author":"SN Taylor","year":"2018","unstructured":"Taylor SN, Morris DH, Avery AK et al (2018) Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea: A Phase 2, Randomized, Dose-Ranging, Single-Oral Dose Evaluation. Clin Infect Dis an off Publ Infect Dis Soc Am 67:504\u2013512","journal-title":"Clin Infect Dis an off Publ Infect Dis Soc Am"},{"key":"3663_CR169","doi-asserted-by":"publisher","DOI":"10.3390\/MOLECULES26092671","author":"M Terreni","year":"2021","unstructured":"Terreni M, Taccani M, Pregnolato M (2021) New Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives. Molecules. https:\/\/doi.org\/10.3390\/MOLECULES26092671","journal-title":"Molecules"},{"key":"3663_CR170","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1371\/journal.pbio.0040185","volume":"4","author":"DM Tobiason","year":"2006","unstructured":"Tobiason DM, Seifert HS (2006) The obligate human pathogen, Neisseria gonorrhoeae, is polyploid. PLoS Biol 4:1069\u20131078","journal-title":"PLoS Biol"},{"key":"3663_CR171","doi-asserted-by":"crossref","unstructured":"Townsend L, Hughes G, Kerr C, Kelly M, O\u2019Connor R, Sweeney E, Doyle C, O\u2019Riordan R, Bergin C, Bannan C (2020) Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection. JAC-antimicrobial Resist 2:dlaa071","DOI":"10.1093\/jacamr\/dlaa071"},{"key":"3663_CR172","first-page":"145","volume":"4","author":"O Umairah","year":"2019","unstructured":"Umairah O, Suresh K (2019) In silico approach for mining of potential drug targets from hypothetical proteins of bacterial proteome. Int J Mol Biol 4:145\u2013152","journal-title":"Int J Mol Biol"},{"key":"3663_CR173","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1128\/CMR.00010-14","volume":"27","author":"M Unemo","year":"2014","unstructured":"Unemo M, Shafer WM (2014) Antimicrobial resistance in Neisseria gonorrhoeae in the 21st Century: Past, evolution, and future. Clin Microbiol Rev 27:587\u2013613","journal-title":"Clin Microbiol Rev"},{"key":"3663_CR174","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/S1473-3099(18)30162-2","volume":"18","author":"M Unemo","year":"2018","unstructured":"Unemo M, Workowski K (2018) Dual antimicrobial therapy for gonorrhoea: what is the role of azithromycin? Lancet Infect Dis 18:486\u2013488","journal-title":"Lancet Infect Dis"},{"key":"3663_CR175","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1128\/AAC.05760-11","volume":"56","author":"M Unemo","year":"2012","unstructured":"Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaouie P (2012) High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: Novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother 56:1273\u20131280","journal-title":"Antimicrob Agents Chemother"},{"key":"3663_CR176","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1586\/14787210.2014.906902","volume":"12","author":"M Unemo","year":"2014","unstructured":"Unemo M, Golparian D, Shafer WM (2014) Challenges with gonorrhea in the era of multi-drug and extensively drug resistance - are we on the right track? Expert Rev Anti Infect Ther 12:653\u2013656","journal-title":"Expert Rev Anti Infect Ther"},{"key":"3663_CR177","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.1128\/AAC.00786-15","volume":"59","author":"M Unemo","year":"2015","unstructured":"Unemo M, Ringlander J, Wiggins C, Fredlund H, Jacobsson S, Cole M (2015) High in vitro susceptibility to the novel spiropyrimidinetrione ETX0914 (AZD0914) among 873 contemporary clinical Neisseria gonorrhoeae isolates from 21 European countries from 2012 to 2014. Antimicrob Agents Chemother 59:5220\u20135225","journal-title":"Antimicrob Agents Chemother"},{"key":"3663_CR178","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1128\/9781555819453.ch12","volume":"10","author":"M Unemo","year":"2016","unstructured":"Unemo M, del Rio C, Shafer WM (2016) Antimicrobial Resistance Expressed by Neisseria gonorrhoeae: A Major Global Public Health Problem in the 21st Century. Emerg Infect 10:213\u2013237","journal-title":"Emerg Infect"},{"key":"3663_CR179","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/978-1-4939-9496-0_3","volume":"1997","author":"M Unemo","year":"2019","unstructured":"Unemo M, Golparian D, Eyre DW (2019a) Antimicrobial Resistance in Neisseria gonorrhoeae and Treatment of Gonorrhea. Methods Mol Biol 1997:37\u201358","journal-title":"Methods Mol Biol"},{"key":"3663_CR180","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1071\/SH19023","volume":"16","author":"M Unemo","year":"2019","unstructured":"Unemo M, Lahra MM, Cole M, Galarza P, Ndowa F, Martin I, Dillon J-AR, Ramon-Pardo P, Bolan G, Wi T (2019b) World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts. Sex Health 16:412\u2013425","journal-title":"Sex Health"},{"key":"3663_CR181","doi-asserted-by":"publisher","first-page":"e627","DOI":"10.1016\/S2666-5247(21)00171-3","volume":"2","author":"M Unemo","year":"2021","unstructured":"Unemo M, Lahra MM, Escher M et al (2021) WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017\u201318: a retrospective observational study. The Lancet Microbe 2:e627\u2013e636","journal-title":"The Lancet Microbe"},{"key":"3663_CR182","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/S1473-3099(14)70780-7","volume":"14","author":"TP Van Boeckel","year":"2014","unstructured":"Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, Laxminarayan R (2014) Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis 14:742\u2013750","journal-title":"Lancet Infect Dis"},{"key":"3663_CR183","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1001\/jama.1941.02820040010004","volume":"116","author":"CJ van Slyke","year":"1941","unstructured":"van Slyke CJ, Wolcott RR, Mahoney JF (1941) THE CHEMOTHERAPY OF GONOCOCCIC INFECTIONS: I. SUMMARY OF EXPERIENCE WITH SULFANILAMIDE II. INVESTIGATION OF CHEMOTHERAPEUTIC EFFECT OF SULFAPYRIDINE. J Am Med Assoc 116:276\u2013280","journal-title":"J Am Med Assoc"},{"key":"3663_CR184","first-page":"277","volume":"40","author":"CL Ventola","year":"2015","unstructured":"Ventola CL (2015) The antibiotic resistance crisis: part 1: causes and threats. P T 40:277\u2013283","journal-title":"P T"},{"key":"3663_CR185","first-page":"197","volume":"3","author":"CK Walker","year":"2011","unstructured":"Walker CK, Sweet RL (2011) Gonorrhea infection in women: prevalence, effects, screening, and management. Int J Womens Health 3:197\u2013206","journal-title":"Int J Womens Health"},{"key":"3663_CR186","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jinf.2018.06.001","volume":"77","author":"S Wang","year":"2018","unstructured":"Wang S, Xue J, Lu P, Ni C, Cheng H, Han R, van der Veen S (2018) Gonococcal MtrE and its surface-expressed Loop 2 are immunogenic and elicit bactericidal antibodies. J Infect 77:191\u2013204","journal-title":"J Infect"},{"key":"3663_CR187","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/infdis\/jiz018","volume":"220","author":"Y Wang","year":"2019","unstructured":"Wang Y, Ferrer-Espada R, Baglo Y, Goh XS, Held KD, Grad YH, Gu Y, Gelfand JA, Dai T (2019) Photoinactivation of Neisseria gonorrhoeae: A Paradigm-Changing Approach for Combating Antibiotic-Resistant Gonococcal Infection. J Infect Dis 220:873\u2013881","journal-title":"J Infect Dis"},{"key":"3663_CR188","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.3201\/eid2206.151093","volume":"22","author":"J Whelan","year":"2016","unstructured":"Whelan J, Kl\u00f8vstad H, Haugen IL, van Holle MR-DR, B, Storsaeter J, (2016) Ecologic Study of Meningococcal B Vaccine and Neisseria gonorrhoeae Infection, Norway. Emerg Infect Dis 22:1137\u20131139","journal-title":"Emerg Infect Dis"},{"key":"3663_CR189","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1136\/sti.2008.032011","volume":"84","author":"RG White","year":"2008","unstructured":"White RG, Moodley P, McGrath N, Hosegood V, Zaba B, Herbst K, Newell M, Sturm WA, Hayes RJ (2008) Low effectiveness of syndromic treatment services for curable sexually transmitted infections in rural South Africa. Sex Transm Infect 84:528\u2013534","journal-title":"Sex Transm Infect"},{"key":"3663_CR190","unstructured":"WHO (World Health Organization) (2012) Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae."},{"key":"3663_CR191","doi-asserted-by":"publisher","unstructured":"WHO (World Health Organization) (2016) Global health sector strategy on Sexually Transmitted Infections, 2016\u20132021\u202f; Towards Ending STI. World Heal Organ. https:\/\/doi.org\/10.1055\/s-2007-970201","DOI":"10.1055\/s-2007-970201"},{"key":"3663_CR192","unstructured":"WHO (2021) Enhanced gonococcal antimicrobial surveillance programme (EGASP): general protocol."},{"key":"3663_CR193","first-page":"217","volume":"46","author":"RR Willcox","year":"1970","unstructured":"Willcox RR (1970) A survey of problems in the antibiotic treatment of gonorrhoea. With special reference to South-East Asia. Br J Vener Dis 46:217\u2013242","journal-title":"Br J Vener Dis"},{"key":"3663_CR194","unstructured":"World Health Organization (WHO) (2016) WHO GUIDELINES FOR THE Treatment of Neisseria gonorrhoeae."},{"key":"3663_CR195","unstructured":"World Health Organization (WHO) (2019) Global Antimicrobial Resistance Surveillance System (GLASS): molecular methods for antimicrobial resistance (AMR) diagnostics to enhance the Global Antimicrobial Resistance Surveillance System. World Health Organization"},{"key":"3663_CR196","unstructured":"World Health Organization (WHO) (2022a) Multi-drug resistant gonorrhoea. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/multi-drug-resistant-gonorrhoea. Accessed 14 May 2023"},{"key":"3663_CR197","unstructured":"World Health Organization (WHO) (2022b) Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report 2022b."},{"key":"3663_CR198","unstructured":"World Health Organization (WHO) (2022c) Multi-drug resistant gonorrhoea. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/multi-drug-resistant-gonorrhoea. Accessed 3 Feb 2022c"},{"key":"3663_CR199","unstructured":"World Health Organization (WHO) (2022d) Global Health Sector Strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022d\u20132030 (GHSS)."},{"key":"3663_CR200","unstructured":"World Health Organization (WHO) (2023a) GASP Network. https:\/\/www.who.int\/initiatives\/gonococcal-antimicrobial-surveillance-programme\/gasp-network. Accessed 18 May 2023a"},{"key":"3663_CR201","unstructured":"World Health Organization (WHO) (2023) WHO Gonococcal AMR Surveillance Programme (WHO-GASP). https:\/\/www.who.int\/data\/gho\/data\/themes\/topics\/who-gonococcal-amr-surveillance-programme-who-gasp. Accessed 18 May 2023"},{"key":"3663_CR202","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3201\/eid1308.060948","volume":"13","author":"S Yokoi","year":"2007","unstructured":"Yokoi S, Deguchi T, Ozawa T, Yasuda M, Ito S, Kubota Y, Tamaki M, Maeda S (2007) Threat to cefixime treatment for gonorrhea. Emerg Infect Dis 13:1275\u20131277","journal-title":"Emerg Infect Dis"},{"key":"3663_CR203","volume":"6","author":"I Yosef","year":"2016","unstructured":"Yosef I, Manor M, Qimron U (2016) Counteracting Selection for Antibiotic-Resistant Bacteria Bacteriophage 6:e1096996","journal-title":"Counteracting Selection for Antibiotic-Resistant Bacteria Bacteriophage"},{"key":"3663_CR204","doi-asserted-by":"publisher","unstructured":"Zeshan B, Karobari MI, Afzal N, et al (2021) The Usage of Antibiotics by COVID-19 Patients with Comorbidities: The Risk of Increased Antimicrobial Resistance. Antibiot (Basel, Switzerland). https:\/\/doi.org\/10.3390\/antibiotics11010035","DOI":"10.3390\/antibiotics11010035"},{"key":"3663_CR205","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","volume":"45","author":"J-M Zhang","year":"2007","unstructured":"Zhang J-M, An J (2007) Cytokines, inflammation, and pain. Int Anesthesiol Clin 45:27\u201337","journal-title":"Int Anesthesiol Clin"},{"key":"3663_CR206","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fmicb.2011.00124","volume":"2","author":"W Zhu","year":"2011","unstructured":"Zhu W, Chen C-J, Thomas CE, Anderson JE, Jerse AE, Sparling PF (2011) Vaccines for gonorrhea: can we rise to the challenge? Front Microbiol 2:124","journal-title":"Front Microbiol"},{"key":"3663_CR207","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines7040153","author":"T Zhu","year":"2019","unstructured":"Zhu T, McClure R, Harrison OB, Genco C, Massari P (2019) Integrated Bioinformatic Analyses and Immune Characterization of New Neisseria gonorrhoeae Vaccine Antigens Expressed during Natural Mucosal Infection. Vaccines. https:\/\/doi.org\/10.3390\/vaccines7040153","journal-title":"Vaccines"},{"key":"3663_CR208","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9020132","author":"SM Zughaier","year":"2020","unstructured":"Zughaier SM, Rouquette-Loughlin CE, Shafer WM (2020) Identification of a Neisseria gonorrhoeae histone deacetylase: Epigenetic impact on host gene expression. Pathogens. https:\/\/doi.org\/10.3390\/pathogens9020132","journal-title":"Pathogens"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-023-03663-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-023-03663-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-023-03663-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T20:22:34Z","timestamp":1730060554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-023-03663-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,9]]},"references-count":208,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["3663"],"URL":"https:\/\/doi.org\/10.1007\/s00203-023-03663-0","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,9]]},"assertion":[{"value":"11 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"330"}}